We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current SEQUA market cap is 33.72M. The company's latest EPS is EUR -1.2954 and P/E is -1.10.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.03M | 970k | 963k | 370k | 923k |
| Operating Income | -13.08M | -13.96M | -17.77M | -22.61M | -28.1M |
| Net Income | -13.98M | -14.98M | -19.11M | -23.61M | -30.76M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 3.34M | 9.35M | 14.21M | 14.71M | 26.03M |
| Total Liabilities | 22.1M | 8.42M | 14.1M | 15.49M | 28.18M |
| Total Equity | -18.76M | 926k | 112k | -787k | -2.15M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -9.87M | -18.48M | -17.01M | -23.62M | -27.48M |
| Investing | -55k | -337k | -142k | -338k | -653k |
| Financing | 9.47M | 23.22M | 22.63M | 22.44M | 37.33M |
| Market Cap | 33.72M |
| Price to Earnings Ratio | -1.10 |
| Price to Sales Ratio | 36.5 |
| Price to Cash Ratio | 1.79 |
| Price to Book Ratio | -15.66 |
| Dividend Yield | - |
| Shares Outstanding | 23.75M |
| Average Volume (1 week) | 28.65k |
| Average Volume (1 Month) | 74.49k |
| 52 Week Change | -58.60% |
| 52 Week High | 4.85 |
| 52 Week Low | 1.35 |
| Spread (Intraday) | 0.05 (3.4%) |
| Company Name | Sequana medical NV |
| Address |
kortrijksesteenweg 1112 box 102 brussels, brussels-capital region 9051 |
| Website | https://www.sequanamedical.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
